Institutional Sign In

Go

Roche Czech Republic - Operating Cost Growth

Roche CR`s Operating Cost Growth reached -75.8 % in 2016. This is 148 % less than in the previous year.

$1.99

Buy Operating Cost Growth data for Roche Czech Republic.

$19.99

Buy all data for Roche Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ...           8.84 -1.44 0.493 -2.18 -1.76    
Bayer Czech Republic % ... ... ...               -158 -257 21.4 12.8 19.2    
GlaxoSmithKline Czech Republic % ... ... ...               -34.4 52.8 -2.39 -1.60 -21.5    
Merck Czech Republic % ... ...                 147 -11.7 -7.57 9.06 13.5    
Novartis Czech Republic %                     8.43 6.24 17.6 39.1 8.21    
Pfizer Czech Republic % ... ...                 -17.5 -49.8 49.5 -8.06 -33.8    
Roche Czech Republic % ... ... ...               -3.47 4.38 2.78 12.6 157   ...
Sanofi-Aventis Czech Republic % ... ... ... ...             2.80 10.9 2.48 -7.42 27.8    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... -12.0 17.6 3.26    
Walmark % ... ... ...               -8.72 12.5 -10.8 20.0 -69.9